ATARA Biotherapeutics (ATRA) Tops Q1 EPS by 350c

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of $3.50. Revenue for the quarter came in at $98.15 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Professional Diversity Network forms AI subsidiary with no assets yet
• Walmart (WMT) PT Lowered to $120 at Baird